Curaleaf Holdings Files July 2025 6-K Report

Ticker: CURLF · Form: 6-K · Filed: 2025-07-08T00:00:00.000Z

Sentiment: neutral

Topics: 6-K, disclosure, foreign-private-issuer

TL;DR

Curaleaf Holdings filed its July 6-K, confirming 40-F annual report status and including a press release.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on July 8, 2025, reporting information for the month of July 2025. The filing indicates that Curaleaf is a foreign private issuer and will file annual reports under Form 40-F. The report includes a press release as Exhibit 99.1. Peter Clateman, Chief Legal Officer, signed the report on behalf of the company.

Why It Matters

This filing provides routine updates and disclosures for Curaleaf Holdings, Inc. as a foreign private issuer, signaling ongoing compliance and operational reporting.

Risk Assessment

Risk Level: low — This is a routine 6-K filing, typically containing press releases or other periodic disclosures, and does not indicate significant new risks.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

This Form 6-K is a report of a foreign private issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of July 2025, and includes Exhibit 99.1, a Press Release.

Which form does Curaleaf Holdings, Inc. use for its annual reports?

Curaleaf Holdings, Inc. will file annual reports under cover of Form 40-F.

Who signed this Form 6-K on behalf of Curaleaf Holdings, Inc.?

Peter Clateman, Chief Legal Officer, signed the report on behalf of Curaleaf Holdings, Inc.

What is the principal executive office address of Curaleaf Holdings, Inc.?

The principal executive office is located at 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada.

When was the company formerly known as LEAD VENTURES INC.?

The company was formerly known as LEAD VENTURES INC. and the date of the name change was October 23, 2018.

From the Filing

0001756770-25-000025.txt : 20250708 0001756770-25-000025.hdr.sgml : 20250708 20250708144114 ACCESSION NUMBER: 0001756770-25-000025 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20250708 FILED AS OF DATE: 20250708 DATE AS OF CHANGE: 20250708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 251110681 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover07082025cihl.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: July 8, 2025 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release EX-99.1 2 pressrelease7825cihl.htm EX-99.1 pressrelease7825cihl Curaleaf Holdings, Inc. Investor Relations Curaleaf Holdings Announces Buyout of Minority Partner in Curaleaf International STAMFORD, Conn., July 8, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA, OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it has acquired the equity stake in Curaleaf International Holdings Limited ("Curaleaf International") previously held by a single strategic institutional investor. The transaction brings the Company's stake in its European holding company to 100%. The transaction represents the completion of a Put/Call Option that was agreed with the strategic investor at the time of its participation in Curaleaf's original investment into Europe in 2021. Following the pricing mechanism incorporated in the Put/Call Option, the investor elected to receive the purchase entirely in Curaleaf Subordinate Voting Shares. The acquisition strengthens the Company's control over its European operations, enabling enhanced strategic alignment across international markets. The request of the strategic investor to settle the transaction for Company shares underscores the investor's long-term support and confidence in the future of Curaleaf. The issuance of the Subordinate Voting Shares in connection with the transaction was conditionally approved by the Toronto Stock Exchange on June 25, 2025, subject to fulfilling customary listing conditions. The transaction was completed on July 2, 2025. Boris Jordan, Executive Chairman of Curaleaf Holdings, Inc., commented: "This consolidation of ownership of our European holding company enables us to streamline decision-making, strengthen alignment across regions, and accelerate our strategic initiatives in Europe with greater autonomy. This development marks another important milestone in Curaleaf's continued commitment to internatio

View on Read The Filing